Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with DWTX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
DWTX
Dogwood Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
DWTX
Dogwood Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only DWTX
3
—
Serpin Pharma
unlisted
supplier
—
Rejuvenation Labs
unlisted
supplier
—
University of Alabama
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,362.91
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
DWTX
Dogwood Therapeutics, Inc.
Change
1.02
▼
−1.04%
· post 1.02
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$35.0M
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 5 '26
delayed
LLY
ELI Lilly & Co
vs
DWTX
Dogwood Therapeutics, Inc.
1,371.32
▼
−3.29%
post 1,362.91
delayed
Price
1.02
▼
−1.04%
post 1.02
delayed
$1.3T
Mkt cap
$35.0M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,371.32
▼
−3.29%
vs
DWTX
1.02
▼
−1.04%
After hours
Nov 5 '26
delayed